Cargando…
Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models
INTRODUCTION: Resistance in anti-cancer treatment is a result of clonal evolution and clonal selection. In chronic myeloid leukemia (CML), the hematopoietic neoplasm is predominantly caused by the formation of the BCR::ABL1 kinase. Evidently, treatment with tyrosine kinase inhibitors (TKIs) is treme...
Autores principales: | Kaehler, Meike, Osteresch, Pia, Künstner, Axel, Vieth, Stella Juliane, Esser, Daniela, Möller, Marius, Busch, Hauke, Vater, Inga, Spielmann, Malte, Cascorbi, Ingolf, Nagel, Inga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294234/ https://www.ncbi.nlm.nih.gov/pubmed/37384296 http://dx.doi.org/10.3389/fonc.2023.1200897 |
Ejemplares similares
-
Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia
por: Kaehler, Meike, et al.
Publicado: (2021) -
Genome-wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor-resistant CML cells
por: Kaehler, Meike, et al.
Publicado: (2022) -
Germline variants in cancer therapy
por: Kaehler, Meike, et al.
Publicado: (2019) -
MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
por: Kaehler, Meike, et al.
Publicado: (2017) -
Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T(3)) supplementation
por: de Assis, Leonardo Vinicius Monteiro, et al.
Publicado: (2022)